|
⚲
|
| Keyboard |
| ProSight Investment LLC
✚
|
|
|---|---|
| CIK # | 0001497474, 0001617201 |
| CIK | Period |
|---|---|
| 0001497474 0001617201 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Nektar Therapeutics | 52.9 | ||
| Boston Scientific Corp | 49.9 | ||
| Janux Therapeutics Inc | 49.3 | ||
| Procept Biorobotics Corp | 48.6 | ||
| CM Life Sciences Inc | 33.6 | ||
| Shattuck Labs Inc | 32.2 | ||
| ADC Therapeutics Sa | 31.1 | ||
| Zeta Acquisition Corp III | 27.3 | ||
| Alnylam Pharmaceuticals Inc | 25.1 | ||
| MeiraGTx Holdings PLC | 22.8 | ||
| Alkermes PLC | 18.2 | ||
| Syndax Pharmaceuticals Inc | 18.0 | ||
| Veeva Systems Inc | 15.2 | ||
| Zymeworks Inc | 13.5 | ||
| Crinetics Pharmaceuticals Inc | 12.7 | ||
| Abivax Sa | 11.7 | ||
| Concentra Group Holdings Parent Inc | 10.8 | ||
| Phreesia Inc | 9.2 | ||
| Reneo Pharmaceuticals Inc | 8.9 | ||
| Corbus Pharmaceuticals Holdings Inc | 6.5 | ||
| Schrodinger Inc | 5.8 | ||
| Emergent Biosolutions Inc | 5.3 | ||
| Roivant Sciences Ltd | 5.0 | ||
| Orthopediatrics Corp | 4.8 | ||
| Health Sciences Acquisitions Corp | 4.4 | ||
| ICU Medical Inc/DE | 3.5 | ||
| AVROBIO Inc | 2.5 | ||
| Inotek Pharmaceuticals Corp | 2.4 | ||
| Prev | Page 1 | Next | |||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001497474] | |
| 4 | [0001497474] | |
| 13F-HR | [0001617201] | |
| SC 13G | [0001617201] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
ProSight Global Inc PROS
Common Stock
|
2021-08-04 | Other | 17,016,059 | $12.85 | 218,656,358 |
|
ProSight Global Inc PROS
Restricted Stock Units · derivative
|
2021-08-04 | Other | 11,043 | $12.85 | 141,903 |
|
ProSight Global Inc PROS
Common Stock
|
2019-08-15 | Sell | 589,285 | $14.00 | 8,249,990 |
|
ProSight Global Inc PROS
Common Stock
|
2019-07-29 | Sell | 1,785,715 | $14.00 | 25,000,010 |
|
Tiptree Inc TIPT
Class A Common Stock
|
2016-06-23 | Sell | 5,596,000 | $6.50 | 36,374,000 |